Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.10 USD
Change Today +0.0052 / 5.71%
Volume 20.1K
ACUS On Other Exchanges
As of 8:10 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

acusphere inc (ACUS) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/6/14 - $1.00
52 Week Low
03/11/15 - $0.06
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ACUSPHERE INC (ACUS)

Related News

No related news articles were found.

acusphere inc (ACUS) Related Businessweek News

No Related Businessweek News Found

acusphere inc (ACUS) Details

Acusphere, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of Imagify (perflubutane polymer microspheres) for injectible suspension. The company’s Imagify acts as a cardiovascular drug for the detection of coronary artery disease by enabling ultrasound to accurately assess myocardial perfusion. It serves customers in the United States, Europe, and Asia. Acusphere, Inc. was founded in 1993 and is headquartered in Lexington, Massachusetts.

acusphere inc (ACUS) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

acusphere inc (ACUS) Key Developments

Acusphere, Inc. Presents at Boston CEO Conference, Jun-04-2014 04:00 PM

Acusphere, Inc. Presents at Boston CEO Conference, Jun-04-2014 04:00 PM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, Massachusetts, United States. Speakers: Mark W. Leuchtenberger, Chief Executive Officer, President and Director.

Acusphere Appoints William Ramage as Chief Development Officer

Acusphere, Inc. announced that William I. Ramage, D. Phil., has been appointed Chief Development Officer. Dr. Ramage brings with him over 30 years of imaging experience, 25 of which have been dedicated to cardiovascular imaging. He served as an Executive Consultant at Acusphere from March 2000 to October 2013 where he was responsible for key clinical and regulatory activities and as an Independent Business Development and Strategic Marketing Consultant from August 1999 until March 2000.

Acusphere, Inc. has Changed its Ticker to ACUS from ACUSD

Effective October 21, 2013, Acusphere, Inc. changed its Pink Sheets LLC stock ticker symbol to ACUS from ACUSD.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACUS:US $0.10 USD +0.0052

ACUS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ACUS.
View Industry Companies

Industry Analysis


Industry Average

Valuation ACUS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.2x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACUSPHERE INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at